Janus Henderson Group PLC Eliem Therapeutics, Inc. Transaction History
Janus Henderson Group PLC
- $187 Billion
- Q3 2024
A detailed history of Janus Henderson Group PLC transactions in Eliem Therapeutics, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 3,606,495 shares of ELYM stock, worth $14.8 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,606,495
Previous 3,253,988
10.83%
Holding current value
$14.8 Million
Previous $23.1 Million
20.65%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding ELYM
# of Institutions
69Shares Held
53.1MCall Options Held
0Put Options Held
0-
Ra Capital Management, L.P. Boston, MA31.4MShares$129 Million2.23% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA2.61MShares$10.7 Million7.7% of portfolio
-
Boxer Capital, LLC San Diego, CA2.6MShares$10.7 Million0.7% of portfolio
-
Deep Track Capital, LP Greenwich, CT2.17MShares$8.92 Million0.41% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.52MShares$6.27 Million0.0% of portfolio
About Eliem Therapeutics, Inc.
- Ticker ELYM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,567,700
- Market Cap $109M
- Description
- Eliem Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in chronic pain, neuropsychiatry, epilepsy, and other disorders of the peripheral and central nervous systems. Its two lead drug candidates are ETX-810 for chronic pain, which is in Phase II...